Giant Biogene Holding Co., Ltd. (2367.HK)

HKD 76.95

(-1.28%)

Revenue Summary of Giant Biogene Holding Co., Ltd.

  • Giant Biogene Holding Co., Ltd.'s latest annual revenue in 2023 was 3.52 Billion CNY , up 49.05% from previous year.
  • Giant Biogene Holding Co., Ltd.'s latest quarterly revenue in 2023 FY was 3.52 Billion CNY , up 49.05% from previous quarter.
  • Giant Biogene Holding Co., Ltd. reported a annual revenue of 2.36 Billion CNY in annual revenue 2022, up 52.3% from previous year.
  • Giant Biogene Holding Co., Ltd. reported a annual revenue of 1.55 Billion CNY in annual revenue 2021, up 30.41% from previous year.
  • Giant Biogene Holding Co., Ltd. reported a quarterly revenue of 802.84 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Giant Biogene Holding Co., Ltd. reported a quarterly revenue of 802.84 Million CNY for 2023 Q1, up 16.39% from previous quarter.

Annual Revenue Chart of Giant Biogene Holding Co., Ltd. (2023 - 2019)

Historical Annual Revenue of Giant Biogene Holding Co., Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 3.52 Billion CNY 49.05%
2022 2.36 Billion CNY 52.3%
2021 1.55 Billion CNY 30.41%
2020 1.19 Billion CNY 24.44%
2019 956.7 Million CNY 0.0%

Peer Revenue Comparison of Giant Biogene Holding Co., Ltd.

Name Revenue Revenue Difference
Natural Beauty Bio-Technology Limited 336.01 Million HKD -948.805%
Innovative Pharmaceutical Biotech Limited 6.59 Million HKD -53352.798%
China Overseas Nuoxin International Holdings Limited 180.99 Million HKD -1847.094%
Prosperous Future Holdings Limited 470.33 Million HKD -649.288%
Huasheng International Holding Limited 565.9 Million HKD -522.744%
Fourace Industries Group Holdings Limited 268.02 Million HKD -1214.861%
Evergreen Products Group Limited 979.24 Million HKD -259.886%
EC Healthcare 4.21 Billion HKD 16.312%
Ming Fai International Holdings Limited 2.06 Billion HKD -70.473%
Blue Moon Group Holdings Limited 7.32 Billion HKD 51.879%
SuperRobotics Holdings Limited 15.08 Million HKD -23268.099%
Takbo Group Holdings Limited 215.59 Million HKD -1534.643%
Hyfusin Group Holdings Limited 866.25 Million HKD -306.827%